In recent years, advocates of telemedicine promised increased access to healthcare, better patient outcomes, and reduced costs. COVID-19 became an unexpected large-scale trial for telehealth. Remote patient monitoring, chronic disease management, virtual appointments, and other aspects of digital medicine showed earlier success in those trials. As vaccines and therapeutics reduce the load on healthcare providers, they should not look to return to their previous standards of care. Instead, they should look to continue with digital healthcare in their post-COVID plans.
This Digital forum featured industry leaders addressing key topics such as the latest trends in digital health impacting delivery of care, dynamic telehealth, eICU, hospital-at-home, rural digital health centers and more.
Avasant’s research and other publications are based on information from the best available sources and Avasant’s independent assessment and analysis at the time of publication. Avasant takes no responsibility and assumes no liability for any error/omission or the accuracy of information contained in its research publications. Avasant does not endorse any provider, product or service described in its RadarView™ publications or any other research publications that it makes available to its users, and does not advise users to select only those providers recognized in these publications. Avasant disclaims all warranties, expressed or implied, including any warranties of merchantability or fitness for a particular purpose. None of the graphics, descriptions, research, excerpts, samples or any other content provided in the report(s) or any of its research publications may be reprinted, reproduced, redistributed or used for any external commercial purpose without prior permission from Avasant, LLC. All rights are reserved by Avasant, LLC.
Login to get free content each month and build your personal library at Avasant.com
